18
MAY
2011
Northwest Biotherapeutics And The Fraunhofer Institute For Cell Therapy And Immunology Are Partnering For Clinical Trials And Compassionate Use Cases in Europe
Comments : Off
Bethesda, Maryland, May 18, 2011 – Northwest Biotherapeutics (OTC Bulletin Board: NWBO) announced today that it is partnering with Fraunhofer for production of DCVax®-L for brain cancer, for clinical trials and compassionate use cases in Europe. Fraunhofer is the largest applied research foundation in Europe, with a staff of more than 18,000 scientists, engineers, business personnel and others dedicated to practical applications and... Read More